Watson Pharmaceuticals, Inc.Parsippany, NJ United States
Company Description
Watson Pharmaceuticals tries to have the best of both worlds, with operations in both the generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about 160 products includes treatments for hypertension and pain, as well as smoking cessation products, antidepressants, and oral contraceptives. Its line of some 30 branded drugs is focused on urology and nephrology and marketed to specialist physicians in the US. Additionally, Watson distributes its own and third-party products to independent pharmacies and health care providers in the US through its Anda and Valmed subsidiaries.
| Morris Corporate Center Iii, 400 Interpace Pkwy. | Phone: 862-261-7000 | http://www.watson.com |
| Parsippany, NJ 07054 | ||
| United States | Toll Free: 800-900-1644 |
Watson Pharmaceuticals, Inc. Rankings
| S&P 500 | #586 in FORTUNE 1000 (May 2011) |
Executives
| 32 executives listed for Watson Pharmaceuticals, Inc.'s Parsippany, NJ location. | ||
| Chairman | Andrew Turner | |
|---|---|---|
| President, CEO, and Director | Paul Bisaro | |
| EVP and CFO | R. ToddJoyce | |
Financials
| Company Type | Public - NYSE: WPI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 6,686 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Watson Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
